U.S. Physical Therapy (USPH) Expected to Announce Earnings on Wednesday

U.S. Physical Therapy (NYSE:USPH) is expected to release its Q3 2025 results after the market closes on Wednesday, November 5th. Analysts expect the company to announce earnings of $0.67 per share and revenue of $193.9760 million for the quarter. Individuals can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, November 6, 2025 at 10:30 AM ET.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The company had revenue of $140.66 million for the quarter. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Trading Down 1.0%

USPH opened at $90.10 on Wednesday. U.S. Physical Therapy has a 52 week low of $62.77 and a 52 week high of $101.19. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30. The business has a fifty day simple moving average of $85.49 and a 200-day simple moving average of $79.18. The firm has a market cap of $1.37 billion, a P/E ratio of 39.35, a P/E/G ratio of 4.56 and a beta of 1.48.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Friday, August 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is 78.60%.

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 763 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $84.97, for a total value of $64,832.11. Following the sale, the chief operating officer owned 21,483 shares of the company’s stock, valued at $1,825,410.51. This trade represents a 3.43% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Eric Joseph Williams sold 1,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $85.25, for a total transaction of $85,250.00. Following the completion of the transaction, the chief operating officer owned 25,331 shares of the company’s stock, valued at $2,159,467.75. This represents a 3.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 6,853 shares of company stock worth $581,406 over the last ninety days. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors have recently modified their holdings of the company. State of Wyoming grew its stake in shares of U.S. Physical Therapy by 85.3% during the second quarter. State of Wyoming now owns 1,575 shares of the company’s stock worth $123,000 after purchasing an additional 725 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in U.S. Physical Therapy by 377.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,746 shares of the company’s stock worth $137,000 after buying an additional 1,380 shares during the last quarter. Brevan Howard Capital Management LP acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter worth about $289,000. Hsbc Holdings PLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at about $410,000. Finally, Snowden Capital Advisors LLC increased its holdings in shares of U.S. Physical Therapy by 3.6% in the 2nd quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company’s stock valued at $438,000 after acquiring an additional 195 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on USPH. Zacks Research raised U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. JPMorgan Chase & Co. began coverage on shares of U.S. Physical Therapy in a research note on Thursday, September 18th. They set an “overweight” rating and a $110.00 target price on the stock. Barrington Research reiterated an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a report on Friday, October 24th. Finally, Wall Street Zen downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Sunday, September 21st. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.